Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 1366 AL 1380

Safety and Efficacy of Fecal Microbiota Transplantation in Alleviating Symptoms of Parkinson's Disease: A Randomized, Placebo-Controlled, Double-Blinded Study

Figura M, Milanowski Ł, Nowak JM, Antoniak A, Kopczyński M, Zając W, Sadowski K, Hołubiuk Ł, Walęcik-Kot W, Szlufik S, Friedman A, Kaczmarczyk B, Biliński J, Koziorowski D.

Ann Neurol. 2026 Jul;100(1):10-21. doi: 10.1002/ana.78153. Epub 2026 Feb 12.

Spectral presaturation with inversion recovery provides superior neuromelanin imaging for Parkinson's disease evaluation compared to magnetization transfer

Imokawa T, Maki H, Kusama M, Kagaya R, Shigemoto Y, Kimura Y, Matsuda H, Yoneyama M, Namiki T, Mukai Y, Yamamoto T, Takahashi Y, Tateishi U, Sato N.

Neuroradiology. 2026 Jul;68(7):1915-1925. doi: 10.1007/s00234-026-03945-6. Epub 2026 Feb 17.

The effectiveness of i-virtual reality and telemedicine based cognitive approach for rehabilitation of prospective memory in individuals with Parkinson's disease and mild cognitive impairment: A randomized-controlled trial

Zabberoni S, De Simone MS, Taglieri S, Tieri G, Cona G, Fiorenzato E, Peppe A, Massimi V, Zannino GD, Carlesimo GA, Antonini A, Caltagirone C, Costa A.

Rehabil Psychol. 2026 Aug;71(3):417-430. doi: 10.1037/rep0000645. Epub 2026 Feb 16.

Rapid Eye Movement Sleep Behavior Disorder with Clinical Dementia with Lewy Bodies Phenotype but Lacking Postmortem Central Nervous System Synuclein Pathology: Alternate Etiologies

Mayà G, Iranzo A, Sánchez-Valle R, Serradell M, Parchi P, Albajar I, Aizpurua M, Aldecoa I, Gelpi E.

Mov Disord. 2026 Jun;41(6):1586-1592. doi: 10.1002/mds.70235. Epub 2026 Feb 18.

Responsiveness and Minimal Clinically Important Difference of Balance Assessment Tools in Parkinson's Disease

Candan Z, Güler MA, Koroglu MA, Yavuzdemir MA, Ata E.

Mov Disord Clin Pract. 2026 Aug;13(8):1907-1917. doi: 10.1002/mdc3.70562. Epub 2026 Feb 18.

Predictive Factors and Impact of Significant Weight Loss on Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study

Vidal ÁS, Santos-García D, de Deus Fonticoba T, Jesús S, Cosgaya M, Caldentey JG, Caballol N, Legarda I, Vara JH, Cabo I, Manzanares LL, Aramburu IG, Rivera AA, Mayordomo VG, Nogueira V, García-Soto JD, Borrué C, Vila BS, Sauco MÁ, Mir P; COPPADIS Study Group.

Mov Disord Clin Pract. 2026 Jul;13(7):1690-1709. doi: 10.1002/mdc3.70552. Epub 2026 Feb 23.

Validity of a Wearable Digital Insole for Assessing Gait ON and OFF in Parkinson's Disease

Hall DA, Kwei K, Acosta RJ, Koyani B, Robertson E, Rai P, Barge R, Timm E, Purcell NL, Desai N, Patel D, Visoiu-Knapp AM, Stuart S, Alaj R, Wipperman MF, Levy O, O'Keefe JA.

Ann Clin Transl Neurol. 2026 Aug;13(8):1662-1672. doi: 10.1002/acn3.70333. Epub 2026 Feb 24.

Schizophrenia and disordered sensorimotor control: challenges, mechanisms and opportunities

Joseph A, Adams RA, Gaughran F, Howes OD, Martino D, Morgante F, Edwards MJ.

Brain. 2026 Jul 7;149(7):2200-2223. doi: 10.1093/brain/awag064.

Baseline Dementia Prevalence and Subtypes in Older Adults Hospitalized With Acute Coronary Syndrome: A Multicenter Study From a Large Integrated Health Care Delivery System

Krishnaswami A, Jain A, Dinh H, Ha RV, Canio WC, Nanna MG, Romero A, Gilsanz P, Aggarwal NT, Mielke MM, Maurer MS, Yang JY, Shin ED, Patel DM, Damluji AA, Shah AI.

Perm J. 2026 Jun 15;30(2):5-13. doi: 10.7812/TPP/25.159. Epub 2026 Mar 10.

Missense Variants in the A Isoform of FGF13 as a Novel Cause of Paroxysmal Dyskinesia

Mignot C, Papathanasiou Terzi MA, Ravelli C, Bosch E, Lin X, Trauffler A, Caumes R, Fry AE, Fort C, Gauthe G, Trollmann R, Wirth T, Anheim M, Méneret A, Roze E, de Sainte Agathe JM, He H, Panagiotakaki E, Lesca G, Reis A, Doummar D, Smol T, Vasileiou G.

Mov Disord. 2026 Jul;41(7):1884-1892. doi: 10.1002/mds.70256. Epub 2026 Mar 11.

Effects of dance movement therapy and other dance-related interventions on depressive symptoms: a meta-analysis of evidence in the past decade

Xing Z.

Eur Arch Psychiatry Clin Neurosci. 2026 Jun;276(4):1505-1519. doi: 10.1007/s00406-026-02205-1. Epub 2026 Mar 13.

Seeking Traditional Health Practitioners and Use of Complementary/Alternative Medicines in the Management of Movement Disorders in Africa: A Multicenter Continental Study

Shalash A, Roushdy T, Ben Sassi S, Ojo O, Jamnagerwalla Y, Sheikh AO, Mecheri Y, Fall M, Gams Massi D, Rasaholiarison N, Sokhi D, Ponte NK, Mwemezi P, Esam M, Marzouki B, Agabi O, Zidan T, Serradj F, Magnerou AM, Touna HE, Lemdaoui I, Marcellin B, Fekraoui BS, Razafimahefa J, Mouandza E, Zouari R, Rachdi A, Diop AM, Kahwagi J, Dekker MCJ, Hooker J, Okubadejo NU, Hamid E.

Mov Disord. 2026 Jun;41(6):1502-1515. doi: 10.1002/mds.70280. Epub 2026 Mar 15.

Parkinson's Disease in Times of War: Gaps in Knowledge and Emerging Controversies

Salari M, Etemadifar M, Soleimani S.

Mov Disord. 2026 Jun;41(6):1362-1369. doi: 10.1002/mds.70272. Epub 2026 Mar 17.

Bridging the gap to clinical translation: the advanced role of PET molecular imaging in stem cell therapy

Cen P, Jin C, Wang J, Zhou R, Zhong Y, Tian M, Zhang H.

Eur J Nucl Med Mol Imaging. 2026 Jul;53(8):4803-4806. doi: 10.1007/s00259-026-07859-6. Epub 2026 Mar 25.

Multiomic and Longitudinal Dissection of Immune Dynamics Associated with Parkinsonism after Ciltacabtagene Autoleucel Therapy

Kadel SK, Scheller L, Leipold AM, Krammer T, Raskó T, Alb M, Weis P, Leberzammer M, Schmitt F, Stetter C, Tamamushi Y, Köck A, Köberle P, Reich M, Musacchio T, Doppler K, Sommer C, Cebulla N, McFleder R, Ip CW, Volkmann J, Kallius M, Serfling SE, Hartrampf PE, Buck AK, Pande A, Löffler D, Gernert M, Duell J, Topp MS, Mersi J, Waldschmidt J, Einsele H, Hudecek M, Saliba AE, Rasche L, Kortüm KM.

Blood Cancer Discov. 2026 Jul 1;7(4):544-557. doi: 10.1158/2643-3230.BCD-25-0278.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias